Skip to main content

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

KIN holding history

Kindred Biosciences, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KIN overviewAll 13F holders of KINFull Q4 2025 holdings

Shares (Q3 2021)
0
Sold out in Q3 2021
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q1 2021
Holdings of KIN by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20210$00.0%−1,890,913−100.0%Sold outHolders
Q2 20211,890,913$17.3M<0.1%−111,957−5.6%ReducedHolders
Q1 20212,002,870$9.95M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.